UPDATE: Roth On Translate Bio: Firm Highlights Revolution Of mRNA Vaccine Technology; Notes Co. Has 1/3 Of R&D Funds Devoted To mRNA Vaccines With Sanofi Along With 10% Of Total Potential Revenues From Any Of The Possible Six Vaccines From Collaboration